Skip to content

Merck & Co. MRK Other income, net (Note 6)

Other income, net (Note 6) at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$32M+90.6%
Pfizer logo
PfizerPFE
Johnson & Johnson logo
Johnson & JohnsonJNJ
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
United Therapeutics logo
United TherapeuticsUTHR
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX

Other financials

Income statement

See full
Revenue$16.3B+4.9%
Gross profit$12.1B-0.2%
Net income-$4.2B-183%
EPS (diluted)-$1.72-186%

Balance sheet

See full
Cash & equivalents$5.4B-38.2%
Total debt$49.1B+35.8%
Total equity$45.9B-5.1%
Total assets$128.69B+11.8%

Cash flow

See full
Operating cash flow$3.9B+56.7%
CapEx$991.0M-25.4%
Free cash flow$2.9B+150%

Valuation

See full
Market cap$308.9B+52.1%
Enterprise value$352.6B+52.0%
P/E34.6×+22.2×
P/S4.7×+1.5×

Profitability

See full
Gross margin73.9%-2.5pp
Net margin13.6%-13.7pp
FCF margin21.5%-5.2pp

Returns & leverage

See full
Return on equity19%-20.3pp
Debt / equity1.1×+0.3×
Current ratio1.3×-0.1×

Where this comes from

Reported directly by Merck & Co. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Merck & Co.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merck & Co.'s other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merck & Co.'s other income, net (note 6)?
Merck & Co. (MRK) reported other income, net (note 6) of -$138M in Q1 2026.
How has Merck & Co.'s other income, net (note 6) changed year-over-year?
Merck & Co.'s other income, net (note 6) decreased by 494.3% year-over-year, from $35M to -$138M.
What is the long-term trend for Merck & Co.'s other income, net (note 6)?
Over 3 years (2021 to 2025), Merck & Co.'s other income, net (note 6) has grown at a -51.6% compound annual growth rate (CAGR), from $1.34B to -$152M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.